Bayer Aktiengesellschaft

Bayer AG is a German multinational life sciences corporation whose Crop Science division—massively expanded through the US$63 billion Monsanto acquisition in 2018—represents the world's second-largest agricultural inputs business. Crop Science encompasses herbicides notably the glyphosate-based Roundup franchise, insecticides, fungicides, corn and soybean seed traits, and the Climate FieldView digital farming platform. With 16,000+ dedicated Crop Science employees and €21.622 billion in 2025 division revenue, Bayer serves farmers in approximately 80 countries.

• Herbicides: Glyphosate-based Roundup franchise plus selective herbicides for corn, soybean, cotton, and cereal crops • Seed Traits & Germplasm: Genetically modified corn, soybean, cotton, and canola varieties with stacked traits for herbicide tolerance and insect resistance corn seed & traits: €7.149 billion in 2025 • Insecticides & Fungicides: Synthetic and biological crop protection chemicals covering major pest and disease spectrums • Seed Treatment & Coatings: Advanced seed-applied technologies including Acceleron and Poncho brands • Digital Farming: Climate FieldView platform providing data-driven planting prescriptions and yield analytics across millions of subscribed acres • Biologicals: Expanding portfolio of biofungicides and biostimulants for integrated pest management and regenerative agriculture

Market Position & Financial Strength

Bayer Crop Science is the global #2 in agricultural inputs with €21.622 billion in 2025 revenue. Core corn seed and traits generated €7.149 billion while herbicides contributed €5.279 billion. However, division EBITDA (before special items) declined 3.2% to €4.188 billion with margin contracting to 14.2%. The parent company's 2025 performance was severely impacted by €5.52 billion in glyphosate litigation special charges, resulting in a €3.62 billion group net loss.

Technological Innovation & Moat

Bayer's competitive moat is built on three pillars: the world's largest proprietary seed germplasm library, the Roundup herbicide system's entrenched farmer adoption, and the Climate FieldView platform's industry-leading digital agronomy subscriber base. The company is pivoting R&D investment toward next-generation short-stature corn hybrids, biological fungicides, and RNAi-based crop protection approaches. The decision to close high-cost Frankfurt production and restructure Dormagen by 2028 signals a strategic shift toward concentrating manufacturing resources on high-moat innovation areas.

Sustainability & Future Outlook

Bayer has committed to reducing Scope 3 greenhouse gas emissions and expanding its portfolio of reduced-risk crop protection products. The biologicals pipeline and digital tools for precision input application align with EU Farm to Fork and global regenerative agriculture mandates. However, the glyphosate litigation overhang remains the single largest risk factor—future settlement trajectories and potential Supreme Court interventions will determine whether Bayer can unlock the full value of its Crop Science franchise. VerityRank Score: 95/100